Among the key players driving these aggressive phenotypes, the transcription factor forkhead box A1 (FOXA1) has been identified as a critical regulator of AR reprogramming, enabling oncogenic transcriptional programs during cancer progression [4,5]. This evidence concerns the gene FOXA1 and cancer.